BMF-219 is the first menin inhibitor to be clinically studied in patients with KRAS-mutated non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC)
A pan-KRAS inhibitor
Qualcomm Inc's (NASDAQ: QCOM) Qualcomm Technologies announced the Snapdragon XR2+ Gen 2 Platform, a single-chip architecture that unlocks 4.3K spatial computing at 90 frames per second for breathtaking visual clarity across work and play.
New Offerings Provide Productivity Solutions for Businesses to Embrace Today's ‘Work from Anywhere' Models
Charter Communications, Inc. (NASDAQ:CHTR), a leading broadband connectivity company serving more